Our findings also indicate that IL-34 is being produced by PDAC CTC in the portal blood and may have a profound effect on skewing myeloid differentiation toward immunosuppression and maintenance of anergy in tumor-directed T cells. The gene discussed is IL34; the disease is neoplasm.